脳神経外科学
Neurosurgery
整理番号 論文の種類 著者名 論文タイトル 誌名、書名等 巻号ページ doi
2247001 原著 Hisamitsu Y, Kubo T, Fudaba H, Sugita K, Fujiki M, Ide S, Kiyosue H, Hori Y. High D-Dimer Concentration Is a Significant Independent Prognostic Factor in Patients with Acute Large Vessel Occlusion Undergoing Endovascular Thrombectomy. World Neurosurg. 160:e487-e493. 2022 10.1016/j.wneu.2022.01.052.
2247002 原著 Iuchi T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa Y, Iwasaki K, Fujiki M, Kumabe T, Sakata Y. Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Neurooncol Adv. 12;4(1):vdab189. 2022 10.1093/noajnl/vdab189.
2247003 原著 Fujiki M, Matsushita W, Kawasaki Y, Fudaba H. Monophasic-Quadripulse Theta Burst Magnetic Stimulation for Motor Palsy Functional Evaluation After Intracerebral Hemorrhage. Front Integr Neurosci. 11;16:827518. 2022 10.3389/fnint.2022.827518.
2247004 症例報告 Aso D, Fudaba H, Hisamitsu Y, Kubo T, Fujiki M. Mycotic pseudoaneurysm in the internal carotid artery secondary to cranial base abscess diagnosed with optic neuritis: a case report. Br J Neurosurg. 24:1-4. 2022 10.1080/02688697.2022.2090503.
2247005 原著 Kuga K, Ozaki H, Fujiki M. Motor-evoked potentials after focal electrical stimulation predict drug-induced convulsion potentials in rats. Toxicol Mech Methods. 22:1-8. 2022 10.1080/15376516.2022.2101038.
2247006 原著 Matsuta H, Shimomura T, Kouchiyama T, Fujiki M. Continuous theta-burst stimulation to the sensorimotor cortex affects contralateral gamma-aminobutyric acid level and resting-state networks. PLoS One. 15;17(8):e0272268. 2022 doi:10.1371/journal.pone.0272268.
2247007 Proceedings Anan M. Takao K, Matsuhita W, Aso D, Fudaba H, Onishi K, Matsuta H, Sugita K, Matsuda T, Kubo T, Nagai Y, Fujiki M Lactate and lactate dehydrogenase in carotid cistern as biomarkers of early brain injury and delayed
cerebral ischemia of aneurysmal subarachnoid hemorrhage
J Stroke https://j-stroke.org/articles/file/KJJSC2022_Abstracts_0917_0918.pdf 2022  
2247008 原著 Higa N, Akahane T, Yokoyama S,  Yonezawa H, Uchida H, Takajo T, Otsuji R, Hamada T, Matsuo K, Kirishima M, Hata H, Hanaya R, Tanimoto A, Yoshimoto K Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma. Neurooncol Adv. 4(1), 1–9: vdac097. 2022 10.1093/noajnl/vdac097
2247009 原著 Funakoshi Y, Takigawa K, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Otsuji R, Sako A, Yoshitake T, Togao O, Hiwatashi A, Iwaki T, Mizoguchi M, Yoshimoto K. Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study.  World Neurosurg. 159:e479-e487. 2022 10.1016/j.wneu.2021.12.075.
2247010 原著 Natsume A, Arakawa Y, Narita Y, Sugiyama K, Hata N, Muragaki Y, Shinojima N, Kumabe T, Saito R, Motomura K, Mineharu Y, Miyakita Y, Yamasaki F, Matsushita Y, Ichimura K, Ito K, Tachibana M, Kakurai Y, Okamoto N, Asahi T, Nishijima S, Yamaguchi T, Tsubouchi H, Nakamura H, Nishikawa R. The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro Oncol. Jun 20:noac155. doi:  Epub ahead of 2022 10.1093/neuonc/noac155.
2247011 原著 Higa N, Akahane T, Yokoyama S, Yonezawa H, Uchida H, Fujio S, Kirishima M, Takigawa K, Hata N, Toh K, Yamamoto J, Hanaya R, Tanimoto A, Yoshimoto K. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel. Neurol Med Chir. 62(9):391-399. 2022 10.2176/jns-nmc.2022-0103.
2247012 症例報告 Fujii Y, Hatae R, Hata N, Suzuki SO, Sangatsuda Y, Takigawa K, Funakoshi Y, Fujioka Y, Kuga D, Mizoguchi M, Iwaki T, Yoshimoto K. A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient. Neuropathology. 42(3):197-203. 2022 10.1111/neup.12793
2247013 著書 藤木 稔 局所性脳損傷とびまん性脳損傷 今日の治療指針2023 50-51 2022  
2247014 原著 Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru J, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H, Fukuda H. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. Neuro Oncol. Nov 5:noac246. 2022 doi:10.1093/neuonc/noac246.